Given that GP73 is regarded as a biomarker for HCC diagnosis [27,28], and its rare expression in healthy tissue [29], it emerges as an optimal therapeutic target with minimal toxicity to normal cells. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.